William Patrick McEvoy III, Chief Investment Officer and a major shareholder of Cypherpunk Technologies Inc., has reported significant stock transactions in a recent SEC filing. This update is crucial as it reveals his substantial ownership stake in the company, which could influence its future strategies and shareholder dynamics.
Background
Cypherpunk Technologies Inc. operates in the pharmaceutical preparations sector, focusing on innovative solutions in life sciences. The company is based in Cambridge, Massachusetts, and has undergone several name changes in its history, including its previous identity as Leap Therapeutics, Inc. and Dekkun Corp. The recent filing is part of a series of disclosures, with the most recent prior filing dated August 19, 2026.
What the Filing Says
According to the filing dated October 14, 2026, McEvoy reported two significant transactions on October 12, 2026. He acquired 4,938,801 shares of common stock at a price of $0.001 per share. Following this transaction, he now owns 29,793,414 shares. Additionally, he reported the exercise of pre-funded warrants for the same number of shares at a price of $0.5196 per share, bringing his total ownership to 97,229,007 shares.
Impact
These transactions may significantly affect Cypherpunk Technologies' shareholder dynamics and overall strategic direction. McEvoy's substantial ownership stake indicates a strong commitment to the company's future, which could influence investor confidence and market perceptions. The filing also notes that the securities are held by Winklevoss Treasury Investments, LLC, a subsidiary of Winklevoss Capital Fund, LLC, managed by the Winklevoss twins, indicating a notable connection to prominent figures in the investment world.
What's Next
The filing does not specify what happens next regarding these transactions or any further actions by McEvoy or the company.